Julie Abraham

2.9k total citations
32 papers, 687 citations indexed

About

Julie Abraham is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Julie Abraham has authored 32 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Julie Abraham's work include Lymphoma Diagnosis and Treatment (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Julie Abraham is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Julie Abraham collaborates with scholars based in France, Belgium and Chile. Julie Abraham's co-authors include Arnaud Jaccard, Benôıt Marin, Bruno François, Anthony Dugard, Philippe Vignon, G. Gondran, H. Gastinne, Frank Bridoux, Éstelle Desport and Jean‐Paul Fermand and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Julie Abraham

29 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Abraham France 13 233 163 158 129 108 32 687
Olga Meltem Akay Türkiye 15 70 0.3× 86 0.5× 69 0.4× 106 0.8× 274 2.5× 83 678
Irma O. Szymanski United States 16 105 0.5× 190 1.2× 201 1.3× 76 0.6× 335 3.1× 39 925
Yoshiya Yamamoto Japan 19 279 1.2× 36 0.2× 162 1.0× 161 1.2× 35 0.3× 71 1.1k
Ami V. Desai United States 18 278 1.2× 38 0.2× 100 0.6× 250 1.9× 53 0.5× 52 1.0k
Alessandro Tomelleri Italy 21 191 0.8× 18 0.1× 97 0.6× 109 0.8× 60 0.6× 84 1.4k
Kaveh Samii Switzerland 16 85 0.4× 32 0.2× 157 1.0× 55 0.4× 219 2.0× 51 755
Mary Guilfoyle United States 10 49 0.2× 117 0.7× 87 0.6× 86 0.7× 347 3.2× 11 592
Amit Lahoti United States 13 168 0.7× 23 0.1× 147 0.9× 279 2.2× 205 1.9× 21 943
P N Badenhorst South Africa 19 103 0.4× 25 0.2× 294 1.9× 52 0.4× 486 4.5× 62 1.1k
Ivan Budnik Israel 14 72 0.3× 72 0.4× 107 0.7× 35 0.3× 491 4.5× 64 763

Countries citing papers authored by Julie Abraham

Since Specialization
Citations

This map shows the geographic impact of Julie Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Abraham more than expected).

Fields of papers citing papers by Julie Abraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Abraham. The network helps show where Julie Abraham may publish in the future.

Co-authorship network of co-authors of Julie Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Abraham. A scholar is included among the top collaborators of Julie Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Abraham. Julie Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drieux, Fanny, Virginie Fataccioli, Vincent Camus, et al.. (2023). Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution. European Journal of Cancer. 197. 113479–113479. 1 indexed citations
2.
3.
Abraham, Julie, et al.. (2022). Changing social dynamics and older population. SHILAP Revista de lepidopterología. 9(1). 34–42. 2 indexed citations
4.
Abraham, Julie, et al.. (2021). CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles. British Journal of Cancer. 125(12). 1687–1698. 6 indexed citations
5.
Saada, Sofiane, Paul‐François Gallet, Nathalie Gachard, et al.. (2020). BDNF belongs to the nurse-like cell secretome and supports survival of B chronic lymphocytic leukemia cells. Scientific Reports. 10(1). 12572–12572. 14 indexed citations
6.
Petit, Barbara, Laurent Désaubry, Armand de Gramont, et al.. (2019). Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects. Journal of Experimental & Clinical Cancer Research. 38(1). 450–450. 19 indexed citations
7.
Woillard, Jean‐Baptiste, Jean Debord, Isabelle Benz‐de Bretagne, et al.. (2017). A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity. Therapeutic Drug Monitoring. 39(2). 145–156. 12 indexed citations
8.
9.
Lengliné, Étienne, Bernard Drénou, Pierre Péterlin, et al.. (2017). Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia. Haematologica. 103(2). 212–220. 45 indexed citations
10.
Deluche, Élise, Stéphane Girault, Pierre Jésus, et al.. (2017). Assessment of the nutritional status of adult patients with acute myeloid leukemia during induction chemotherapy. Nutrition. 41. 120–125. 18 indexed citations
11.
Bridoux, Frank, Nianhang Chen, Stéphane Moreau, et al.. (2016). Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment. Cancer Chemotherapy and Pharmacology. 78(1). 173–182. 16 indexed citations
12.
Abraham, Julie, Éstelle Desport, Benôıt Marin, et al.. (2015). Hepatocyte growth factor measurement in AL amyloidosis. Amyloid. 22(2). 112–116. 8 indexed citations
13.
14.
Desport, Éstelle, Frank Bridoux, Christophe Sirac, et al.. (2012). AL Amyloidosis. Orphanet Journal of Rare Diseases. 7(1). 54–54. 166 indexed citations
15.
Desport, Éstelle, Julie Abraham, Sébastien Delbès, et al.. (2011). Traitement actuel de l’amylose AL. Néphrologie & Thérapeutique. 7(6). 467–473.
16.
Loustaud‐Ratti, V., Annick Rousseau, Julie Abraham, et al.. (2011). Non-invasive detection of hepatic amyloidosis: FibroScan, a new tool. Amyloid. 18(1). 19–24. 27 indexed citations
17.
Hanf, William, Éstelle Desport, Julie Abraham, et al.. (2011). Actualités dans le traitement du myélome avec insuffisance rénale. Néphrologie & Thérapeutique. 7(6). 457–466. 2 indexed citations
18.
Abraham, Julie, Franck Geneviève, Pascale Lepelley, et al.. (2010). A GEIL flow cytometry consensus proposal for quantification of plasma cells: Application to differential diagnosis between MGUS and myeloma. Cytometry Part B Clinical Cytometry. 80B(3). 176–185. 17 indexed citations
19.
Jaccard, Arnaud, Julie Abraham, Christian Récher, et al.. (2009). Lenalidomide Therapy in Nine Patients with POEMS Syndrome.. Blood. 114(22). 3872–3872. 7 indexed citations
20.
Vignon, Philippe, Anthony Dugard, Julie Abraham, et al.. (2007). Focused training for goal-oriented hand-held echocardiography performed by noncardiologist residents in the intensive care unit. Intensive Care Medicine. 33(10). 1795–1799. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Meltem Akay Breakdown of academic impact, for papers by Irma O. Szymanski Breakdown of academic impact, for papers by Yoshiya Yamamoto Breakdown of academic impact, for papers by Ami V. Desai Breakdown of academic impact, for papers by Alessandro Tomelleri Breakdown of academic impact, for papers by Kaveh Samii Breakdown of academic impact, for papers by Mary Guilfoyle Breakdown of academic impact, for papers by Amit Lahoti Breakdown of academic impact, for papers by P N Badenhorst Breakdown of academic impact, for papers by Ivan Budnik
Rankless by CCL
2026